Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BH3-mimetics: recent developments in cancer therapy
Paul A. Townsend, M. V. Kozhevnikova, Olivier Cexus, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy
Ryungsa Kim, Takanori Kin, William T. Beck
Cancers (2024) Vol. 16, Iss. 5, pp. 984-984
Open Access | Times Cited: 21
BH3-Only Proteins Noxa and Puma Are Key Regulators of Induced Apoptosis
Rabih Roufayel, Khaled Younes, Ahmed Al-Sabi, et al.
Life (2022) Vol. 12, Iss. 2, pp. 256-256
Open Access | Times Cited: 58
Regulation of Bcl-2 Family Proteins in Estrogen Receptor-Positive Breast Cancer and Their Implications in Endocrine Therapy
Anna Kawiak, Anna Kostecka
Cancers (2022) Vol. 14, Iss. 2, pp. 279-279
Open Access | Times Cited: 39
Cell death pathways: molecular mechanisms and therapeutic targets for cancer
Shaohui Wang, Sa Guo, Jing Guo, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 14
Overcoming therapy resistance in pancreatic cancer: New insights and future directions
Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116492-116492
Open Access | Times Cited: 10
Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma
Sophia M. Lauer, Mitchell H. Omar, Martin Golkowski, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113678-113678
Open Access | Times Cited: 6
Autophagy and senescence facilitate the development of antiestrogen resistance in ER positive breast cancer
Michael K. McGrath, Ali Abolhassani, Luke Guy, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6
Mechanisms of Cancer Resistance to Various Therapies
Asiya Batool, Waseem Rashid, Kaneez Fatima, et al.
(2024), pp. 31-75
Closed Access | Times Cited: 5
A PHASE 1 FIRST-IN-HUMAN STUDY OF THE MCL-1 INHIBITOR AZD5991 IN PATIENTS WITH RELAPSED/REFRACTORY HEMATOLOGIC MALIGNANCIES
Pinkal Desai, Sagar Lonial, Amanda F. Cashen, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 21, pp. 4844-4855
Open Access | Times Cited: 5
Enhanced Apoptosis and Loss of Cell Viability in Melanoma Cells by Combined Inhibition of ERK and Mcl-1 Is Related to Loss of Mitochondrial Membrane Potential, Caspase Activation and Upregulation of Proapoptotic Bcl-2 Proteins
Zhe Peng, Bernhard Gillissen, Antje Richter, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4961-4961
Open Access | Times Cited: 12
IKK-mediated TRAF6 and RIPK1 interaction stifles cell death complex assembly leading to the suppression of TNF-α-induced cell death
Choong-Sil Lee, Gyuho Hwang, Young Woo Nam, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 6, pp. 1575-1584
Closed Access | Times Cited: 12
Recent advances in canonical versus non-canonical Ca2+-signaling-related anti-apoptotic Bcl-2 functions and prospects for cancer treatment
Claire Cauwelier, Ian de Ridder, Geert Bultynck
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 5, pp. 119713-119713
Closed Access | Times Cited: 4
Mcl-1 mediates intrinsic resistance to RAF inhibitors in mutant BRAF papillary thyroid carcinoma
Maria R. Cavallo, Jacob Yo, Kayla C. Gallant, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Evasion of apoptosis and treatment resistance in squamous cell carcinoma of the head and neck
Ben O’Leary, Heath D. Skinner, Jonathan D. Schoenfeld, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102773-102773
Open Access | Times Cited: 4
The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target
Daniela Verzella, Jessica Cornice, Paola Arboretto, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2233-2233
Open Access | Times Cited: 17
Injectable Senolytic Hydrogel Depot for the Clearance of Senescent Cells
Lorenza Garau Paganella, Giovanni Bovone, Filippo Cuni, et al.
Biomacromolecules (2025)
Open Access
Ubiquitin and ubiquitin-like proteins in HPV-driven carcinogenesis
Louisa M. Wootton, Ethan L. Morgan
Oncogene (2025)
Open Access
VDAC2 and Bak scarcity in liver mitochondria enables targeting hepatocarcinoma while sparing hepatocytes
Shamim Naghdi, Piyush Mishra, Soumya Sinha Roy, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
The pan-BH-3 mimetic, obatoclax, synergistically enhances cisplatin-induced apoptosis in oral squamous cell carcinoma through a mechanism that involves degradation of the pro-survival protein Mcl-1
Tianyi Gao, Stefania Magnano, Marlener. Quadros, et al.
Archives of Oral Biology (2025), pp. 106250-106250
Closed Access
CB-5083 and luteolin synergistically induce the apoptosis of bladder cancer cells via multiple mechanisms
Shuben Sun, Ping Liu, Guohai Xie, et al.
Toxicology and Applied Pharmacology (2025), pp. 117333-117333
Open Access
Life of the cell: Is it important how cells die?
Tamara Kravic‐Stevovic, Tamara Martinović, Darko Ćirić, et al.
Medicinska istrazivanja (2025) Vol. 58, Iss. 1, pp. 61-73
Closed Access
S-Nitrosylation at the intersection of metabolism and autophagy: Implications for cancer
Silvia Guil‐Luna, María Teresa Sánchez‐Montero, Antonio Rodríguez‐Ariza
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189012-189012
Open Access | Times Cited: 8
BCL-G: 20 years of research on a non-typical protein from the BCL-2 family
Mariusz L. Hartman, Małgorzata Czyż
Cell Death and Differentiation (2023) Vol. 30, Iss. 6, pp. 1437-1446
Open Access | Times Cited: 7
Senolytic and senomorphic interventions to defy senescence-associated mitochondrial dysfunction
Jan O. Nehlin
Advances in protein chemistry and structural biology (2023), pp. 217-247
Closed Access | Times Cited: 7
Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer
J. Robert McCorkle, Rebecca Ahn, Connie D. Cao, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1321-1321
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top